Doctor profile · Federal record
Dr. JOHN SCALLY, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Specialist · Cardiovascular Disease Physician · O FALLON, IL
- NPI 1508952318
- Accepts Medicare
- MIPS 92.6 / 100 · 2023
- 26 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
THREE SAINT ELIZABETH BLVD STE 2800
O FALLON, IL 622691282
(618) 233-6044
fax (833) 973-4218
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- December 21, 2021
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State licenses (3)
- Illinois #036128843 · Illinois #036090218 · Indiana #01056859A
- Medicaid
- IL #036128843
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508952318. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,229
Distinct HCPCS
10
Medicare allowed
$287,382
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 822 | 627 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 712 | 551 | $127 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 437 | 415 | $68 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 285 | 272 | $14 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 203 | 82 | $21 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 190 | 80 | $30 | |
G0250 |
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 151 | 31 | $9 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 129 | 77 | $81 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 101 | 100 | $133 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 93 | 17 | $73 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 134. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$2,260
Transactions
20
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Edwards Lifesciences Corporation | 5 | $1,340.99 | |
| Abbott Laboratories | 13 | $828.87 | |
| Amgen Inc. | 1 | $64.68 | |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $25.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,834
Patients
1,148
Total drug cost
$590,991
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 411 | 99 | $397,035 |
| Atorvastatin Calcium | Generic | 393 | 119 | $6,455 |
| Metoprolol Succinate | Generic | 377 | 113 | $8,271 |
| Metoprolol Tartrate | Generic | 310 | 105 | $2,609 |
| Warfarin Sodium | Generic | 299 | 73 | $4,598 |
| Rosuvastatin Calcium | Generic | 282 | 84 | $4,962 |
| Furosemide | Generic | 269 | 97 | $1,996 |
| Carvedilol | Generic | 266 | 76 | $2,779 |
| Losartan Potassium | Generic | 233 | 65 | $3,043 |
| Lisinopril | Generic | 230 | 77 | $2,415 |